Torrent Pharmaceuticals Limited (TORNTPHARM) - Net Assets

Latest as of September 2025: Rs84.49 Billion INR ≈ $913.73 Million USD

Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) has net assets worth Rs84.49 Billion INR (≈ $913.73 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs155.15 Billion ≈ $1.68 Billion USD) and total liabilities (Rs70.66 Billion ≈ $764.16 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check TORNTPHARM financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs84.49 Billion
% of Total Assets	54.46%
Annual Growth Rate	17.24%
5-Year Change	30.05%
10-Year Change	123.96%
Growth Volatility	10.89

Torrent Pharmaceuticals Limited - Net Assets Trend (2005–2025)

This chart illustrates how Torrent Pharmaceuticals Limited's net assets have evolved over time, based on quarterly financial data. Also explore Torrent Pharmaceuticals Limited assets under control for the complete picture of this company's asset base.

Annual Net Assets for Torrent Pharmaceuticals Limited (2005–2025)

The table below shows the annual net assets of Torrent Pharmaceuticals Limited from 2005 to 2025. For live valuation and market cap data, see Torrent Pharmaceuticals Limited (TORNTPHARM) total market value.

Year	Net Assets	Change
2025-03-31	Rs75.91 Billion ≈ $820.94 Million	+10.72%
2024-03-31	Rs68.56 Billion ≈ $741.47 Million	+10.62%
2023-03-31	Rs61.98 Billion ≈ $670.29 Million	+4.12%
2022-03-31	Rs59.53 Billion ≈ $643.79 Million	+1.98%
2021-03-31	Rs58.37 Billion ≈ $631.27 Million	+21.02%
2020-03-31	Rs48.23 Billion ≈ $521.61 Million	+2.09%
2019-03-31	Rs47.24 Billion ≈ $510.92 Million	+2.20%
2018-03-31	Rs46.23 Billion ≈ $499.93 Million	+6.25%
2017-03-31	Rs43.51 Billion ≈ $470.50 Million	+28.36%
2016-03-31	Rs33.89 Billion ≈ $366.56 Million	+36.07%
2015-03-31	Rs24.91 Billion ≈ $269.39 Million	+30.91%
2014-03-31	Rs19.03 Billion ≈ $205.78 Million	+33.79%
2013-03-31	Rs14.22 Billion ≈ $153.82 Million	+18.79%
2012-03-31	Rs11.97 Billion ≈ $129.49 Million	+16.92%
2011-03-31	Rs10.24 Billion ≈ $110.74 Million	+23.23%
2010-03-31	Rs8.31 Billion ≈ $89.87 Million	+27.67%
2009-03-31	Rs6.51 Billion ≈ $70.39 Million	+27.74%
2008-03-31	Rs5.10 Billion ≈ $55.11 Million	+24.21%
2007-03-31	Rs4.10 Billion ≈ $44.37 Million	+17.94%
2006-03-31	Rs3.48 Billion ≈ $37.62 Million	+10.24%
2005-03-31	Rs3.16 Billion ≈ $34.12 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Torrent Pharmaceuticals Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 35548.9% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component	Amount	Percentage
Retained Earnings	Rs47.47 Billion	62.53%
Common Stock	Rs1.69 Billion	2.23%
Other Comprehensive Income	Rs26.75 Billion	35.24%
Other Components	Rs5.40 Million	0.01%
Total Equity	Rs75.91 Billion	100.00%

Torrent Pharmaceuticals Limited Competitors by Market Cap

The table below lists competitors of Torrent Pharmaceuticals Limited ranked by their market capitalization.

Company	Market Cap
Sprott Physical Silver TO:PSLV	$15.33 Billion
CF Industries Holdings Inc NYSE:CF	$15.33 Billion
Azrieli Group Ltd TA:AZRG	$15.34 Billion
Rogers Communications Inc TO:RCI-B	$15.36 Billion
Ningbo Tuopu Group Co Ltd SHG:601689	$15.29 Billion
Falabella SN:FALABELLA	$15.29 Billion
LI AUTO INC. (SP.ADR)/2 F:L87A	$15.28 Billion
VODACOM GROUP LTD. SP.ADR F:5VD0	$15.26 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Torrent Pharmaceuticals Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 68,561,500,000 to 75,910,000,000, a change of 7,348,500,000 (10.7%).
Net income of 19,110,000,000 contributed positively to equity growth.
Dividend payments of 10,830,000,000 reduced retained earnings.
Other comprehensive income decreased equity by 696,100,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rs19.11 Billion	+25.17%
Dividends Paid	Rs10.83 Billion	-14.27%
Other Comprehensive Income	Rs-696.10 Million	-0.92%
Other Changes	Rs-235.40 Million	-0.31%
Total Change	Rs-	10.72%

Book Value vs Market Value Analysis

This analysis compares Torrent Pharmaceuticals Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 18.66x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 448.88x to 18.66x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-03-31	Rs9.32	Rs4185.10	x
2006-03-31	Rs10.28	Rs4185.10	x
2007-03-31	Rs12.12	Rs4185.10	x
2008-03-31	Rs15.06	Rs4185.10	x
2009-03-31	Rs19.23	Rs4185.10	x
2010-03-31	Rs24.55	Rs4185.10	x
2011-03-31	Rs30.21	Rs4185.10	x
2012-03-31	Rs35.27	Rs4185.10	x
2013-03-31	Rs42.01	Rs4185.10	x
2014-03-31	Rs56.21	Rs4185.10	x
2015-03-31	Rs73.59	Rs4185.10	x
2016-03-31	Rs100.13	Rs4185.10	x
2017-03-31	Rs128.53	Rs4185.10	x
2018-03-31	Rs136.57	Rs4185.10	x
2019-03-31	Rs139.59	Rs4185.10	x
2020-03-31	Rs142.51	Rs4185.10	x
2021-03-31	Rs172.47	Rs4185.10	x
2022-03-31	Rs175.89	Rs4185.10	x
2023-03-31	Rs183.13	Rs4185.10	x
2024-03-31	Rs202.58	Rs4185.10	x
2025-03-31	Rs224.31	Rs4185.10	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Torrent Pharmaceuticals Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 25.17%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 16.59%
• Asset Turnover: 0.77x
• Equity Multiplier: 1.97x
Recent ROE (25.17%) is above the historical average (23.93%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2005	15.45%	8.90%	0.77x	2.25x	Rs172.08 Million
2006	14.62%	5.26%	1.03x	2.71x	Rs160.79 Million
2007	22.79%	7.20%	1.24x	2.55x	Rs524.88 Million
2008	26.43%	9.94%	1.07x	2.48x	Rs837.21 Million
2009	28.33%	11.31%	0.98x	2.56x	Rs1.19 Billion
2010	27.82%	12.07%	0.98x	2.36x	Rs1.48 Billion
2011	26.42%	12.73%	0.83x	2.49x	Rs1.68 Billion
2012	23.79%	10.95%	0.84x	2.57x	Rs1.65 Billion
2013	30.43%	13.48%	0.85x	2.66x	Rs2.91 Billion
2014	34.90%	14.27%	0.92x	2.66x	Rs4.74 Billion
2015	30.15%	16.14%	0.59x	3.18x	Rs5.02 Billion
2016	50.82%	25.83%	0.74x	2.66x	Rs13.83 Billion
2017	21.46%	16.05%	0.57x	2.33x	Rs4.99 Billion
2018	14.67%	11.40%	0.42x	3.08x	Rs2.16 Billion
2019	9.23%	5.69%	0.54x	2.99x	Rs-361.55 Million
2020	21.25%	12.91%	0.57x	2.91x	Rs5.42 Billion
2021	21.45%	15.64%	0.57x	2.41x	Rs6.68 Billion
2022	13.06%	9.13%	0.65x	2.20x	Rs1.82 Billion
2023	20.09%	12.94%	0.64x	2.42x	Rs6.25 Billion
2024	24.16%	15.44%	0.71x	2.20x	Rs9.71 Billion
2025	25.17%	16.59%	0.77x	1.97x	Rs11.52 Billion

Industry Comparison

This section compares Torrent Pharmaceuticals Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $23,713,303,062
Average return on equity (ROE) among peers: 8.81%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Torrent Pharmaceuticals Limited (TORNTPHARM)	Rs84.49 Billion	15.45%	0.84x	$15.32 Billion
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$988.60 Million	6.59%	1.36x	$27.93 Million
Aarti Drugs Limited (AARTIDRUGS)	$6.52 Billion	21.67%	1.42x	$371.43 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$19.90 Billion	13.69%	0.46x	$725.68 Million
Abbott India Limited (ABBOTINDIA)	$36.99 Billion	32.48%	0.40x	$5.85 Billion
Ajanta Pharma Limited (AJANTPHARM)	$1.16 Billion	12.69%	1.32x	$3.81 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$6.25 Billion	-40.39%	3.91x	$906.19 Million
Alkem Laboratories Limited (ALKEM)	$88.47 Billion	18.60%	0.59x	$6.98 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$1.46 Billion	16.82%	0.29x	$178.52 Million
Alembic Pharmaceuticals Limited (APLLTD)	$51.90 Billion	11.24%	0.50x	$1.60 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$23.50 Billion	-5.26%	1.65x	$8.73 Billion

About Torrent Pharmaceuticals Limited

NSE:TORNTPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$15.32 Billion

Rs1.42 Trillion INR

Market Cap Rank

#1583 Global

#49 in India

Share Price

Rs4185.10

Change (1 day)

-1.10%

52-Week Range

Rs3127.80 - Rs4446.00

All Time High

Rs4446.00